Abstract
Extrapulmonary β2-adrenoceptor mediated responses to salbutamol were evaluated in 9 healthy female subjects during the follicular (day 2–4, Visit 1) and luteal (day 21–23, Visit 2) phases of the menstrual cycle, and were compared with those of 9 age-matched male controls. At each visit, salbutamol was given by intravenous infusion for 30 minutes at a dose of 0.2 mg · kg−1 · min−1. Plasma salbutamol concentration and responses in heart rate (HR), finger tremor (Tr), Q-T interval (Q-Tc), serum potassium (K), serum insulin (Ins) and serum glucose (Glu) were measured at baseline and at 10, 20 and 30 minutes after commencing the infusion. Comparisons were made between sexes and between visits for peak responses calculated as percentage change from baseline.
Mean plasma salbutamol concentration (ng · ml−1) were not significantly different between males and females on Visit 1: 6.9 (95% CI 6.01, 7.82) vs 7.3 (95% CI 6.4, 8.3), or on Visit 2: 6.9 (95% CI 6.0, 7.8) vs 7.2 (95% CI 6.3, 8.1). On Visit 1, significantly greater responses were demonstrated in females, compared with males for K (as mean difference): 6 (95% CI 1, 11)%, Tr: 17 (95% CI 1, 33)%, Q-Tc: 8 (95% CI 2, 14)% and Ins: 276 (95% CI 71, 481)%. In addition, a significantly greater response was demonstrated in females on Visit 1 compared with males on Visit 2 for HR (as mean difference): 32 (95% CI 1, 63)%, and for Ins: 262 (95% CI 57, 467)%.
Thus, despite no difference in plasma salbutamol concentrations, female subjects exhibited greater responsiveness to salbutamol compared with males during the follicular phase of the menstrual cycle. This suggests that in vivo, females have enhanced sensitivity of extrapulmonary β2-adrenoceptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rahman ARA, McDevitt DG, Struthers AD, Lipworth BJ (1992) Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline. Thorax 47: 1056–1059
Wheeldon NM, Newnham DM, Coutre WJ, Peters JA, McDevitt DG, Lipworth BJ (1994) Influence of sex-steroid hormones on the regulation of lymphocyte β2-adrenoceptors during the menstrual cycle. Br J Clin Pharmacol 37: 583–588
Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, Clark GA, McDevitt DG (1989) Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 37: 567–571
Shamroth L (1982) An introduction to electrocardiography. Blackwell, Oxford, pp 141–144
Bazett HC (1920) An analysis of the time relations of electrocardiograms. Heart 7: 353–370
Lipworth BJ, McDevitt DG (1989) Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 36: 239–245
Johansson SR, Hjalmarson A (1988) Age and sex differences in cardiovascular reactivity to adrenergic agonists, mental stress and isometric exercise in normal subjects. Scand J Clin Lab Invest 48: 183–191
Gibbs CJ, Coutts II, Lock R, Finnegan OC, White RJ (1984) Premenstrual exacerbation of asthma. Thorax 39: 833–836
Hanley SP (1981) Asthma variation with menstruation. Br J Dis Chest 75: 306–308
Pauli BJ, Reid RL, Munt PW, Wigle RD, Forket L (1989) Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis 140: 358–362
Benyon HLC, Garbett ND, Barnes PJ (1988) Severe premenstrual exacerbations of asthma: Effect of intramuscular progesterone. Lancet II: 370–372
Brodde OE, Brinkmann M, Schemuth R, O'Hara N, Daul A (1985) Terbutaline-induced desenitization of human lymphocyte β2-adrenoceptors: accelerated restoration of beta-adrenoceptor responsiveness by prednisolone and ketotifen. J Clin Invest 76: 1096–1101
Hauck RW, Bohm M, Genegebach S, Sunder-Plassmann L, Fruhmann G, Erdmann E (1990) β2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline treated patients. Chest 98: 376–381
Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dykman JH, Sterk PJ (1992) Long-term effects of a long-acting β2-adrenoceptor agonist, salmeterol, on airway hyper-responsiveness in patients with mild asthma. N Engl J Med 327: 1198–1203
Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP (1994) Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 88: 363–368
O'Connor BJ, Aikman S, Barnes PJ (1992) Tolerance to the non-bronchodilator effects of inhaled β2-agonists in asthma. N Engl J Med 327: 1204–1208
Newnham DW, McDevitt DG, Lipworth BJ (1994) Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med 97 (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Newnham, D.M., Wheeldon, N.M., McFarlane, L.C. et al. Extrapulmonary β2-responses to intravenous salbutamol during the menstrual cycle. Eur J Clin Pharmacol 46, 511–515 (1994). https://doi.org/10.1007/BF00196107
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00196107